American Century Companies’s Aceragen Inc ACGN Stock Holding History

American Century Companies’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-172	Closed	-$40K	–	1406
2017 Q2	$40K	Buy	+172	New	+$45K	﹤0.01%	1321

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Century Companies's ACGN Position: Q3 2017 in Review

American Century Companies sold out of Aceragen Inc (ACGN) in Q3 2017, closing a stake of 172 shares — an estimated $40K sold.

American Century Companies first reported a position in ACGN in Q2 2017 and held it in 1 quarter. The position peaked at $40K in Q2 2017. 78 funds tracked by Wall St. Rank hold ACGN as of Q3 2017.

American Century Companies reported no remaining Aceragen Inc position as of Q3 2017 after selling out during the quarter.
American Century Companies sold 172 Aceragen Inc shares in Q3 2017, an estimated $40K.
American Century Companies first reported a position in Aceragen Inc in Q2 2017 and held it in 1 quarter.
American Century Companies's Aceragen Inc position peaked at $40K in Q2 2017.
78 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2017.

Based on American Century Companies's 13F filing for Q3 2017, filed 1 Nov 2017.